Work

Phase 1 Study of the Novel Kinesin Spindle Protein Inhibitor ARRY-520 + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.4082.4082

Authors: Jatin J. Shah, Donna M. Weber, Sheeba K. Thomas, Raymond Alexanian, Michael Wang, Muzaffar H. Qazilbash, Simrit Parmar, Nina Shah, Qaiser Bashir, Uday R. Popat, Brandi Hilder, Robert Z. Orlowski

Institutions: The University of Texas MD Anderson Cancer Center, Array BioPharma (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2569801315

FWCI: 4.869

Cites:

Cited by: 32

Related to: 10